Wells Fargo & Company Nova Bay Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.11 - $147.37 $0 - $1,326	9 Added 3.27%	284 $0
Q2 2022 Aug 12, 2022	BUY	$0.18 - $0.31 $6 - $11	36 Added 15.06%	275 $0
Q1 2022 May 16, 2022	BUY	$0.27 - $0.4 $6 - $9	24 Added 11.16%	239 $0
Q4 2021 Feb 14, 2022	BUY	$0.38 - $0.61 $5 - $9	15 Added 7.5%	215 $0
Q3 2021 Nov 15, 2021	BUY	$0.58 - $0.69 $17 - $20	30 Added 17.65%	200 $0
Q2 2021 Aug 16, 2021	SELL	$0.61 - $0.97 $0 - $0	-1 Reduced 0.58%	170 $0
Q4 2020 Feb 09, 2021	SELL	$0.52 - $0.81 $3,818 - $5,947	-7,343 Reduced 97.72%	171 $0
Q3 2020 Nov 05, 2020	BUY	$0.72 - $1.61 $61 - $138	86 Added 1.16%	7,514 $5,000
Q1 2020 May 14, 2020	BUY	$0.29 - $1.5 $2,154 - $11,142	7,428 New	7,428 $4,000

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $46.1M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.